A detailed history of Ffg Partners, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Ffg Partners, LLC holds 17,051 shares of LLY stock, worth $13.6 Million. This represents 5.23% of its overall portfolio holdings.

Number of Shares
17,051
Previous 12,031 41.73%
Holding current value
$13.6 Million
Previous $10.9 Billion 38.68%
% of portfolio
5.23%
Previous 4.29%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Dec 09, 2024

BUY
$772.14 - $960.02 $3.88 Million - $4.82 Million
5,020 Added 41.73%
17,051 $15.1 Billion
Q2 2024

Dec 09, 2024

SELL
$724.87 - $909.04 $62,338 - $78,177
-86 Reduced 0.71%
12,031 $10.9 Billion
Q1 2024

Dec 09, 2024

BUY
$592.2 - $792.28 $40,861 - $54,667
69 Added 0.57%
12,117 $9.43 Billion
Q4 2023

Dec 03, 2024

BUY
$525.19 - $619.13 $6.33 Million - $7.46 Million
12,048 New
12,048 $7.02 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Ffg Partners, LLC Portfolio

Follow Ffg Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ffg Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ffg Partners, LLC with notifications on news.